Cytokinetics Inc. planned insider sales
In the twelve months since 9 October 2025 insiders at Cytokinetics Inc. filed 30 Form 144 notices of planned sales, 672,913 shares worth $47.4 million at the time of filing, from 12 sellers. The latest, filed 15 September 2026: Robert I. Blum (president, ceo, director), 97,926 shares worth $7.1 million, planned for around 15 September 2026 through J.P. Morgan Securities LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 15 September 2026 | Robert I. Blum | President, CEO, Director | 97,926 | $7.1 million | 15 September 2026 | J.P. Morgan Securities LLC | Transfer | Form 144 |
| 11 September 2026 | Robert Landry | Director | 2,000 | $147,240 | 11 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 1 September 2026 | B Lynne Parshall | Director | 5,000 | $354,550 | 1 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 30 July 2026 | Andrew Callos | Officer | 24,000 | $1.9 million | 30 July 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 7 July 2026 | Fady Malik | Officer | 24,500 | $2.1 million | 7 July 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 1 July 2026 | Robert Blum | Director, Officer | 52,500 | $4.5 million | 1 July 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 29 June 2026 | Sung Lee | Officer | 9,503 | $781,052 | 29 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 26 June 2026 | Sung Lee | Officer | 6,695 | $540,956 | 26 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 24 June 2026 | Sung Lee | Officer | 38,730 | $3.1 million | 24 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 1 June 2026 | Edward Kaye | Director | 2,933 | $225,137 | 1 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 5 May 2026 | Wendell Wierenga | Director | 4,032 | $266,314 | 5 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 5 May 2026 | John Henderson | Director | 20,000 | $1.3 million | 5 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 5 May 2026 | Sung Lee | Officer | 23,906 | $1.6 million | 5 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted stock units and performance stock units | Form 144 |
| 15 April 2026 | Andrew Callos | Officer | 79,639 | $5.3 million | 15 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 7 April 2026 | Fady Malik | Officer | 22,000 | $1.4 million | 7 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 1 April 2026 | Robert Blum | Director, Officer | 45,000 | $3.0 million | 1 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 31 March 2026 | Andrew Callos | Officer | 3,639 | $229,148 | 31 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 18 March 2026 | Andrew Callos | Officer | 1,930 | $119,911 | 18 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 16 March 2026 | Andrew Callos | Officer | 1,709 | $102,643 | 16 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 2 March 2026 | B Lynne Parshall | Director | 10,000 | $622,200 | 2 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 2 January 2026 | Andrew Callos | Officer | 59,570 | $3.8 million | 2 January 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Performance Stock Units | Form 144 |
| 29 December 2025 | Andrew Callos | Officer | 1,809 | $114,166 | 29 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Performance Stock Units | Form 144 |
| 22 December 2025 | Wendell Wierenga | Director | 20,000 | $1.3 million | 22 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 5 December 2025 | Andrew Callos | Officer | 53,528 | $3.6 million | 5 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 2 December 2025 | John T Henderson | Director | 8,750 | $577,938 | 2 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 1 December 2025 | Edward Kaye | Director | 28,064 | $1.9 million | 1 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 19 November 2025 | B Lynne Parshall | Director | 5,000 | $330,800 | 19 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 12 November 2025 | Edward Kaye | Director | 5,175 | $321,885 | 11 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 27 October 2025 | Wendell Wierenga | Director | 4,375 | $253,006 | 27 October 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 21 October 2025 | Fady Malik | Officer | 11,000 | $652,850 | 21 October 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read more
Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.Source
Form 144 filings on EDGAR for Cytokinetics Inc.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.